John Sperzel

2021

In 2021, John Sperzel earned a total compensation of $3.5M as President, Chief Executive Officer and Chairman of the Board of Directors at T2 Biosystems, a 1% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$460,000
Salary$562,500
Stock Awards$2,480,000
Other$3,000
Total$3,505,500

Sperzel received $2.5M in stock awards, accounting for 71% of the total pay in 2021.

Sperzel also received $460K in non-equity incentive plan, $562.5K in salary and $3K in other compensation.

Rankings

In 2021, John Sperzel's compensation ranked 3,820th out of 12,415 executives tracked by ExecPay. In other words, Sperzel earned more than 69.2% of executives.

ClassificationRankingPercentile
All
3,820
out of 12,415
69th
Division
Manufacturing
1,563
out of 5,501
72nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
200
out of 801
75th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
124
out of 522
76th
Industry
Surgical and Medical Instruments and Apparatus
79
out of 327
76th
Source: SEC filing on August 26, 2022.

Sperzel's colleagues

We found two more compensation records of executives who worked with John Sperzel at T2 Biosystems in 2021.

2021

Alec Barclay

T2 Biosystems

SVP and Chief Operations Officer

2021

Michael Gibbs

T2 Biosystems

General Counsel

News

You may also like